WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2014194245) CDK8 INHIBITORS AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/194245    International Application No.:    PCT/US2014/040320
Publication Date: 04.12.2014 International Filing Date: 30.05.2014
IPC:
A61K 31/519 (2006.01)
Applicants: NIMBUS IRIS, INC. [US/US]; 25 First Street, Suite 404 Cambridge, Massachusetts 02141 (US)
Inventors: ROMERO, Donna L.; (US).
CHAUDHARY, Divya; (US).
ROBINSON, Shaughnessy; (US).
MASSE, Craig E.; (US).
MORIN, Michael J.; (US)
Agent: MCLEAN, Thomas H.; Choate, Hall & Stewart LLP Two International Place Boston, Massachusetts 02110 (US)
Priority Data:
61/829,840 31.05.2013 US
Title (EN) CDK8 INHIBITORS AND USES THEREOF
(FR) INHIBITEURS DE CDK8 ET LEURS UTILISATIONS
Abstract: front page image
(EN)The present invention provides methods of using compounds of formula (I) and compositions thereof for the inhibition of CDK8, and the treatment of CDK8-mediated disorders. Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful for treating a variety of diseases, disorders or conditions, associated with regulation of signaling pathways implicating CDK8 kinases. Such diseases, disorders, or conditions include those described herein. Compounds provided by this invention are also useful for the study of CDK8 enzymes in biological and pathological phenomena; the study of intracellular signal transduction pathways occurring in bodily tissues; and the comparative evaluation of new CDK8 inhibitors or other regulators of kinases, signaling pathways, and cytokine levels in vitro or in vivo.
(FR)La présente invention concerne des procédés consistant à utiliser les composés représentés par la formule (I); et des compositions associées pour l'inhibition de CDK8, et le traitement de troubles médiés par CDK8.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)